Real-world data (RWD) is increasingly being used to facilitate and enhance clinical research in oncology. Opportunities for using RWD in oncology trials include assessing protocol feasibility by overlaying trial eligibility criteria onto a RWD source, identifying patients from RWD sources for inclusion in external control arms, and using RWD to augment data collection in long-term follow-up studies following gene therapy trials. However, it is easy to underestimate the challenges that arise in implementation.
Take a look at one of our dynamic sessions from October's virtual forum, Rethinking Clinical Trials in Oncology, where Syneos' Ann Collins, Vice President, Clinical Development, and David Thompson, Senior Vice President, Real World Research, discuss the opportunities and challenges for RWD in oncology trials.
Be sure to RSVP for the May 19, 2021 forum.
Please note: That all fields marked with an asterisk (*) are required.